RxDoctor Payments Data

Sonja Hilburn

Family · Elizabethtown, NCNPI 1235875543

Payments from drug & device makers

$1,280in general payments, 2019–2025

Across 85 payments — averaging $15.05 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Amgen$549
  • AbbVie$271
  • Lilly USA, LLC$242
  • Novo Nordisk$113
  • Exact Sciences$27
  • Biofrontera Inc.$21
  • plus $58 from 4 others

What the payments were for

  • Food & beverage$1,280100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,280 in reported general payments places this provider in the 75th percentile of 4,522 family providers in North Carolina.

See all family providers in North Carolina

Medicare billing

Part B allowed, 2024
$15,718
Medicare patients
61
Services billed
1,678

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide66$74,582
MounjaroTirzepatide52$63,347
Repatha SureclickEvolocumab21$13,405
ProgesteroneProgesterone, Micronized26$584
SynthroidLevothyroxine Sodium11$462
Albuterol Sulfate HfaAlbuterol Sulfate15$403
Metoprolol Succinate13$290
Ezetimibe-SimvastatinEzetimibe/Simvastatin12$271
Pantoprazole Sodium23$245
Duloxetine Hcl17$219
Propranolol Hcl ErPropranolol Hcl12$217
Felodipine ErFelodipine12$216
Hydrochlorothiazide79$201
Tamsulosin Hcl21$199
Ondansetron Hcl18$183

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$113$74,58266 claims
Lilly USA, LLCMounjaro$242$63,34752 claims
AbbVieSynthroid$271$46211 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 4,522 family providers in North Carolina.

Other family in Elizabethtown

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →